United Therapeutics Corporation (UTHR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 266.05 |
| Open | 266.00 |
| Bid | 264.21 x 100 |
| Ask | 264.48 x 100 |
| Day's range | 264.01 - 269.81 |
| 52-week range | 204.44 - 269.81 |
| Volume | |
| Avg. volume | 530,333 |
| Market cap | 11.725B |
| Beta (5Y monthly) | 0.54 |
| PE ratio (TTM) | 12.52 |
| EPS (TTM) | 21.11 |
| Earnings date | 31 July 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 300.95 |
ZacksInsmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates
Insmed (INSM) Q1 earnings beat estimates while sales miss the mark. Management posts positive data readouts from mid-stage studies on its experimental inhalation powder in PH-ILD and PAH indications.
- Zacks
Iovance (IOVA) Q1 Earnings Surpass, Sales Lag Estimates
Iovance (IOVA) reports mixed first-quarter results. Shares gain on encouraging initial demand for the recently-approved melanoma drug Amtagvi in the United States.
ZacksCRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
© 2024 Yahoo. All rights reserved.